PDF Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
[Pages:1]J A N 4 11 15
FEB 2 5
2326 M A R
15
APR 5
19
MAY 9
J U N 5 11
30 J U L
11 17 26 A U G
20 31 S E P 4
OCT 1
1517 2931 N O V
15 19
DEC
Eurofins acquires Tsing Hua
Eurofins acquires NMDL-LCPL
SGS acquires
Eurofins acquires
Labortoire de
City Analysts
Controle et d'Analyse
Eurofins acquires Labo Van Poucke
INC Research and
SGS acquires
inVentiv Health
TraitGenetics
change name to
Syneos Health
Worldwide Clinical Trials acquires Continuum's late stage practice
Cognizant acquires Bolder Healthcare Solutions
Frontage acquires Concord Biosciences
Eurofins acquires PHAST
Premier Research acquires Regulatory Professionals Inc.
Covance acquires Sciformix
Accelovance merges with Linical
Bracket merges with CRF Health
Nuvisan acquires Galderma R&D site
SGS acquires Polymer Solutions Incorporated
Synteract acquires Cu-Tech
Syneos Health acquires Kinapse
Eurofins acquires Clinical Research Laboratories
Eurofins acquires EnvironeX
Eurofins acquires Dermscan
Synteract acquires Medical Review O cers Certification Council
Oracle acquires GoBalto
Novotech Altasciences acquires CNS acquires SNBL
Synteract acquires KinderPharm
Gross revenues for the top 5, publically-listed companies by sector
PHARMA
$75 $68.6B
$71.1B
$70.9B
$72.7B
$50
$72.1B
Billions (USD)
$25
$0 Q3, 2017
CRO
$5
$3.71B
$2.5
Q4, 2017 $4.15B
Q1, 2018 $4.2B
Q2, 2018 $4.26B
Q3, 2018 $4.36B
THERAPEUTIC AREAS
Oncology was the most prevalent therapeutic area, with 17 drugs approved.
Oncology (17)
Infectious Disease (12)
Immunology (8)
(5)
Neurology (8)
Genetic Disease (6)
Gastroenterology
Billions (USD)
Musculoskeltal
Gynecology (3)
Pulmonology (4)
$0 Q3, 2017
CMO
$1.5
$1
$1.24B
Billions (USD)
$0.5
$0 Q3, 2017
Q4, 2017 $1.38B
Q4, 2017
Q1, 2018 $1.41B
Q1, 2018
Q2, 2018 $1.45B
Q2, 2018
Q3, 2018 $1.26B
Q3, 2018
Hematology (15)
Dermatology (6)
Urology (2)
MOLECULE TYPE
The Food and Drug Administration made 59 Novel Drug Approvals in 2018.
17 Biologics
42 Small Molecules
(3)
Other Therapeutic Areas (5)
24,946 studies were launched in 2018. The top locations for these are shown below.
UNITED STATES
8,617 clinical trials launched
FRANCE
1,898 clinical trials launched
CHINA
1,808 clinical trials launched
CANADA
1,332 clinical trials launched
UNITED KINGDOM
1,165 clinical trials launched
GERMANY
950 clinical trials launched
SPAIN
913 clinical trials launched
ITALY
746 clinical trials launched
SOUTH KOREA
722 clinical trials launched
BELGIUM
564 clinical trials launched
Recipharm buys out Nitin Life Sciences
Lonza US expansions announced
Almac annonces Ireland expansion
Almac UK new lab announcement
Almac opens new UK facility, Catalent completes Singapore expansion
Siegfried acquires Arena Pharma facility
Recipharm completes France expansion
WuXi Biologics announces China expansion
Almac completes US expansion
Catalent completes US expansion
Lonza opens new US facility
Catalent announces US expansion
Patheon announces US expansion
WuXi Biologics announces new Ireland facility
Lonza announces US expansion
Cambrex completes US expansion
WuXi Biologics announces new China facility
Catalent completes US expansion
WuXi Biologics announces new Singapore facility
Cambrex announces Sweden expansion
WuXi Biologics announces new US facility
Wockhardt opens new UAE facility
Recipharm completes Sanofi UK site acquisition
WuXi Biologics announces new China facility
Evonik announces US, Canada expansions
Catalent completes Juniper Pharmaceuticals acquisition
Cambrex acquires Almac completes Cambrex
Lonza completes
Halo Pharma, Lonza UK expansion announces Italy Switzerland
begins US expansion
Evonik completes US, Germany expansions;
Catalent completes Italy expansion, Lonza opens
expansion, Lonza expansion
announces Switzerland expansion
CordenPharma opens new Italy facility
invests in new Germany, Slovakia facilities
new Switzerland AMRI completes
facility
Spain expansion
Vetter
Cambrex acquires Avista Pharma
Lonza announces Cambrex
Switzerland
announces
expansion
US expansion
announces Germany expansion
WuXi Biologics breaks ground on new China facility
Catalent, Evonik announce US expansions
Lonza announces China expansion
Catalent announces China expansion
JAN 2
18 24 F E B
20 28 M A R
1215 21
APR
1012 16 242730 M A Y 4 15-17 22 31 J U N
1113 20 27 J U L
27 A U G
13
SEP
12 1920 25 O C T 24 89
24 N O V 5 8
2022 27 D E C 3 10
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- pdf industry briefs 2 the pulse on study conduct 3 drug device
- pdf the rosen law firm p a united states district court
- pdf history and mission services
- pdf cro industry global compensation turnover survey overview
- pdf created
- pdf professional and research experience
- pdf at syneos health we are seeking an experienced statistical
- pdf jan feb mar apr may jun jul aug sep oct nov dec
- pdf 11 18 promis targets parkinson s disease—alzheimer s is next
- pdf syneos health inc investment research
Related searches
- msn today in history aug 10
- i bond rate nov 2019
- today in history msn nov 4
- nov 13 events in cincinnati
- secnav m 5210 2 aug 2018
- election day nov 2020 constitutional amendments
- army promotion list aug 2020
- va nov well septic requirements
- full moon in aug 2020
- dow jones futures for aug 10
- oct 31 dec 25
- june july aug 2020 calendar